Whether it is investing in a lightning-fast quest to develop drugs and vaccines to combat global pandemics, developing cutting-edge technologies to enhance research possibilities or coping with an everchanging regulated environment, the Life Sciences industry is constantly transforming, adapting, and innovating. Consequently, the Life Science leaders of tomorrow will be those who adapt to the changes, those with a clear vision, ready to grab new opportunities and face challenges, building up collaboration beyond traditional players, and seeking the best available resources and partners on the market.

ALTEN has released its latest magazine, highlighting recent advancements in life sciences. The publication showcases ALTEN’s practical case studies and features insights from senior experts on future trends, offering practitioners a global perspective and innovative operational strategies.

ALTEN: Innovation is Central to Growth

ALTEN accompanies their Clients in developing and manufacturing Life Sciences products. By leveraging a deep understanding of the sector’s complexities along with cutting-edge technological expertise, ALTEN has been instrumental in accelerating the development of innovative healthcare solutions. Our collaboration with leading pharmaceutical companies has led to the faster time-to-market of safe and effective medication. Our involvement in biomedical technology has facilitated the creation of advanced medical devices, improving patient outcomes and healthcare delivery. ALTEN’s commitment to excellence and innovation not only drives progress in the Life Sciences field but also exemplifies our role as a key partner for our customers.

ALTEN Experts Talking

Tiago | CSV (Computer System Validation) Specialist

ALTEN helps their Clients grow and meet the regulatory needs in an increasingly digitalised world, to ensure accuracy, reliability, data integrity, and patient safety of pharmaceutical products.

Charlotte | Senior Manager

It"s not just about achieving success; it’s about establishing ALTEN Life Sciences as a trusted partner in the pharmaceutical landscape.

Stan | Practice Leader

Through the position I hold today, I am making a positive impact by being responsible for supporting the delivery of their medicine in a safer way and getting medicine faster to the patients.

Transforming Challenges into Opportunities

Trends — The life sciences market is constantly evolving, with technological, regulatory, and economic pressures driving everchanging trends. At ALTEN, these changes continually prompt further developments in a sector where every day counts for patients.

01 What is ALTEN’s perspective?

ALTEN applies a multidimensional approach to address these trends. In response to economic pressures, Aixial’s CRO comprehensive services enhance R&D efficiency, containing costs without sacrificing innovation or quality. Additionally, ALTEN aligns Client operations with global ESG standards, boosting compliance and competitiveness. Furthermore, we are well-positioned to address the challenges posed by supply chain vulnerabilities. With a presence in over 30 countries, ALTEN’s local embedding near manufacturing and R&D clusters ensures a balance between local production and global operational efficiencies. In terms of digitalisation, ALTEN, together with SDG and Lincoln, uses AI to optimise trials and manufacturing, reducing time to market and improving quality. We ensure secure and transparent data management, leveraging ALCOA+ and blockchain. To address the MedTech and Pharma convergence, ALTEN leverages its engineering roots and strong life sciences expertise to drive innovation at this intersection. Through Aixial, ALTEN enhances patient care with advanced therapies and diagnostics, integrating both fields.

02 What is our Group’s added value?

ALTEN’s added value lies in our comprehensive and tailored approach to meet Client needs. We deliver services spanning the entire product lifecycle, from early R&D to regulatory compliance and market release, which ensure seamless project progression. This is complemented by ALTEN’s unique glocal synergy. Our global expertise, enhanced by local execution, effectively meets diverse regulatory and market demands. Central to these capabilities is our integrated technical direction, supported by a sturdy delivery framework and centres of excellence. This combination provides tailored solutions and guarantees high-quality standards.

03 How ALTEN’s Life Sciences Division is Leading the way in Market Innovation？

The ALTEN Labs

A key testament to our commitment is our labs. Established in 2016, these labs were introduced to empower consultants to experiment with pioneering technologies such as big data, artificial intelligence, UI/UX design, SAFe methodology, virtual and augmented reality, and digital twin technology. In 2019, the 11 labs became part of our Innovation Department, intending to offer Clients innovative value propositions that integrate engineering and digital expertise with business services. One of these labs, the Smart Healthcare Program (ALTEN x Aixial), is dedicated to digitizing the healthcare system, combining data analysis and artificial intelligence, and conducting the development of cutting-edge IoT technologies. Its goal is to facilitate the development and implementation of virtual/decentralized clinical trials using connected solutions, AI, and real-life data, all while ensuring their reliability and safety.

Investing in Artificial Intelligence

Fully aware of the transformative potential of artificial intelligence in advancing innovation, we have proactively invested in it through SDG, our AI & Data Management specialized subsidiary, to leverage this technology across all sectors, particularly in life sciences. Through this collaboration, we aim to find solutions to reduce the production cycles of documentation, accelerate the time to market for medicines and minimize the human error.

Supporting Manufacturing 4.0

Drawing from our extensive experience in industries like automotive and aerospace, we have applied the principles of Manufacturing 4.0 to the healthcare sector, addressing areas such as data traceability in the production chain, digital twins, and more. This approach encompasses automation and smart manufacturing (we assist healthcare clients in implementing advanced manufacturing techniques, enhancing efficiency, precision, and scalability) but also cross-industry expertise by leveraging our knowledge from other high-tech industries, enabling us to deliver innovative solutions that are both reliable and cutting edge.

BETTER

Life sciences are the realm of progress. However, innovation in service of patients only truly makes sense when advancements prove robust, free from adverse effects, and ethically impeccable. A subtle equation at the heart of the work carried out by ALTEN.

FASTER

Whether we are talking about drug discovery, delivery or working process, it is clear that in life sciences, the time is ripe for acceleration. AI, automation, and advanced analytics change the game in expediting clinical trials, optimizing manufacturing processes, and reducing time to market for new therapies. Indeed, it’s a race against time in the service of life, and ALTEN is fully committed to it.

STRONGER

For an organization, strength is not an end in itself, but a basic necessity for survival. Nowhere is this clearer than in life sciences. ALTEN’s approach is to gather and cultivate the best talents and, thanks to technology, give them the time to concentrate on high-value tasks and generate reliable results.

Scan to obtain the magazine